Literature DB >> 3257184

Correlation of bronchoalveolar lavage cell populations with clinical severity of Pneumocystis carinii pneumonia.

R L Smith1, W M el-Sadr, M L Lewis.   

Abstract

We correlated bronchoalveolar lavage (BAL) cell populations with clinical course and outcome in 19 patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome. Twelve patients demonstrated an elevated (greater than or equal to 5 percent) BAL combined neutrophil and eosinophil count, which correlated with the magnitude of the alveolar-arterial PO2 gradient. Patients with elevated BAL granulocytes also had significantly higher serum lactate dehydrogenase levels. Three of the four patients who died had the highest percentage of neutrophil counts observed in lavage fluid. Although no patient was thought to have a concurrent bacterial infection, potential pathogens were cultured from the sputum of patients with the most elevated neutrophil counts. Whether BAL granulocytes reflect an inflammatory process analogous to the adult respiratory distress syndrome or signify concomitant bacterial infection remains to be determined. We conclude that BAL granulocytes are associated with more severe respiratory compromise in patients with Pneumocystis carinii pneumonia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257184     DOI: 10.1378/chest.93.1.60

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  Bronchoalveolar lavage in HIV infected patients with interstitial pneumonitis.

Authors:  J de Blic; S Blanche; C Danel; M Le Bourgeois; M Caniglia; P Scheinmann
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

2.  Bronchoalveolar lavage cell analysis in patients with human immunodeficiency virus related diseases.

Authors:  V Plaza; P Jiménez; A Xaubet; C Picado; A Torres; C Agustí; A Agustí-Vidal
Journal:  Thorax       Date:  1989-04       Impact factor: 9.139

3.  Use of bronchoscopy in the diagnosis of infection in the immunocompromised host.

Authors:  R P Baughman
Journal:  Thorax       Date:  1994-01       Impact factor: 9.139

4.  Postoperative respiratory failure due to acute eosinophilic pneumonia.

Authors:  R C St John; J N Allen; E R Pacht
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

5.  Cellular profiles of bronchoalveolar lavage fluid and their prognostic significance for non-HIV-infected patients with Pneumocystis jirovecii pneumonia.

Authors:  Ju Young Lee; Hyun Jung Park; Yong Kyun Kim; Shinae Yu; Yong Pil Chong; Sung-Han Kim; Heungsup Sung; Sang-Oh Lee; Mi-Na Kim; Chae-Man Lim; Yang Soo Kim; Younsuck Koh; Jun Hee Woo; Sang-Ho Choi
Journal:  J Clin Microbiol       Date:  2015-02-11       Impact factor: 5.948

6.  Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice.

Authors:  Steve D Swain; Terry W Wright; Peter M Degel; Francis Gigliotti; Allen G Harmsen
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

7.  Prognostic factors of early fatal outcome and long-term survival in patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.

Authors:  A Antinori; G Maiuro; F Pallavicini; F Valente; G Ventura; G Marasca; R Murri; E Pizzigallo; G Camilli; E Tamburrini
Journal:  Eur J Epidemiol       Date:  1993-03       Impact factor: 8.082

8.  MyD88 signaling regulates both host defense and immunopathogenesis during pneumocystis infection.

Authors:  Sheila N Bello-Irizarry; Jing Wang; Carl J Johnston; Francis Gigliotti; Terry W Wright
Journal:  J Immunol       Date:  2013-11-29       Impact factor: 5.422

9.  Predicting in-hospital outcome in HIV-associated Pneumocystis carinii pneumonia.

Authors:  T Bauer; S Ewig; E Hasper; J K Rockstroh; B Lüderitz
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

10.  Pulmonary hypertension can be a sequela of prior Pneumocystis pneumonia.

Authors:  Steve D Swain; Soo Han; Ann Harmsen; Katie Shampeny; Allen G Harmsen
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.